对于转移抑制的NIR-II光热免疫疗法的金氨酸纳米激活剂的分子工程
Yingzhe Wang1, Anqi Shen1, Mingwang Yang2
1School of Basic Medical Sciences, Henan University, Kaifeng, China.
Advanced healthcare materials
|January 16, 2026
概括
研究人员开发了用于三阴性乳腺癌 (TNBC) 治疗的新型纳米粒子. 这些药物使用近红外光来产生热量,摧毁瘤,并促进免疫系统以改善癌症清除.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症研究 癌症研究
背景情况:
- 三重阴性乳腺癌 (TNBC) 提出了治疗方面的挑战.
- 对于光热免疫疗法来说,开发用于第二次近红外 (NIR-II) 窗口的有效药物至关重要.
- 现有的药物往往在瘤透和有效性方面面临限制.
研究的目的:
- 为TNBC设计和合成一个分子量身定制的NIR-II响应的有机免疫光热剂.
- 创建具有高光热转换效率 (PCE) 的稳定纳米粒子 (NP),用于深层组织透.
- 评估局部高热和全身免疫调节在TNBC治疗中的协同效应.
主要方法:
- 通过结构操纵合成了一种具有红移吸收 (1022 nm) 的新型光热敏化剂 (BOQCyCN).
- 与DSPE-mPEG2000一起组装BOQCyCN,以形成稳定的纳米粒子 (NP).
- 在TNBC模型中,在NIR-II辐射 (1064 nm,0.6 W cm−2) 下研究了NP性能.
主要成果:
- BOQCyCN NPs表现出高光热转换效率 (62.9%) 和稳定性.
- 实现显著的原发性瘤切除 (95%体积减少) 和抑制转移 (96%减少远端瘤负担).
- 诱导强化的T细胞透和重编程的巨细胞免疫表型向亲炎性M1.
结论:
- 开发的BOQCyCN纳米平台有效地结合了TNBC的高热和免疫治疗.
- 这种热免疫学方法对协同瘤清除和转移抑制有希望.
- 该研究建立了一个可翻译的范式,用于使用NIR-II响应代理来管理TNBC.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


